Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 15 peer-reviewed journal articles Updated
Pediatric Hepatology

Building Your Child's Care Team

At a Glance

Children with familial hypercholanemia may need a pediatric hepatologist and genetics support, with dietitian or psychosocial help added for growth, malabsorption, vitamin concerns, or family stress. Organized genetic, laboratory, growth, and imaging records make visits more useful, while parental testing clarifies recurrence risk.

Because Familial Hypercholanemia (FHC) is a rare condition that often “hides” behind mild symptoms, your child’s health benefits from specialized input. However, the care team should be tailored to your child’s needs; an asymptomatic child with isolated NTCP deficiency does not necessarily need a large multidisciplinary team at a tertiary center [1][2].

Your Core Care Team

You should have access to pediatric hepatology and genetics as needed, with other specialists added based on growth, malabsorption, vitamin deficiency, or symptoms:

  • Pediatric Hepatologist: This is a liver specialist for children. They ensure that time-sensitive emergencies have been ruled out and monitor your child’s liver enzymes and bile acids [3][1].
  • Medical Geneticist and Genetic Counselor: They interpret your child’s genetic testing, determine if the specific variants in the SLC10A1 or BAAT genes are truly disease-causing, and explain inheritance risks [4][5].
  • Pediatric Registered Dietitian: Highly recommended if there are issues with growth or malabsorption. They help manage the absorption of fat-soluble vitamins (A, D, E, and K) and adjust diet as needed [6][7][4].
  • Social Worker or Psychologist: Caring for a child with a rare disease can be stressful. These professionals provide support and connect you with rare-disease communities [8].

Inheritance and Recurrence Risk

FHC is generally inherited in an autosomal recessive pattern. If and only if both biological parents are confirmed carriers of pathogenic variants in the relevant gene, there is a 25% chance with each pregnancy that the child will be affected. There is a 50% chance the child will be a carrier, and a 25% chance they will be unaffected. Parental testing and expert variant interpretation are required to determine if this calculation applies to your family.

Preparing for the First Visit

Because FHC is rare, bringing organized medical records helps the specialist see the full picture and prevents unnecessary repeat testing [9].

What to Bring:

  1. The Full Genetic Report: Do not bring just a summary. The specialist needs to see the specific details of the gene changes to determine if they are pathogenic (known to cause disease) or variants of uncertain significance (VUS) [10][11]. You don’t have to interpret the raw report yourself; the genetic counselor will do that with you.
  2. A Longitudinal Lab Table: Create a folder of all blood tests in chronological order. Key markers include Total/Direct Bilirubin, ALT, AST, GGT, and Serum Bile Acids [12][13].
  3. Growth Charts: Bring copies of your child’s weight and length measurements. Consistent growth is an excellent sign of health [4][9].
  4. Imaging and Biopsy Reports: If your child had an ultrasound, a HIDA scan (a nuclear medicine test that tracks bile flow), or a liver biopsy, bring the written reports [9][7].

The Role of Research and Registries

Since FHC affects a very small number of people, specialists may ask if you wish to participate in rare disease registries [14][15]. These groups pool data to better understand the condition.

  • Participation is strictly voluntary.
  • It involves privacy and consent considerations and does not change your child’s treatment.
  • Families should never pursue additional invasive tests merely to qualify for a registry [8].

By arriving prepared with organized records and the right specialists, you shift from a “wait and see” approach to an active, informed partnership in your child’s long-term health.

Common questions in this guide

Which specialists should care for my child with familial hypercholanemia?
A pediatric hepatologist and a medical geneticist or genetic counselor are the core contacts when specialized input is needed. A pediatric dietitian can help if growth, malabsorption, or fat-soluble vitamin concerns occur, while a social worker or psychologist can provide family support. An asymptomatic child may not need a large multidisciplinary team.
What should I bring to my child’s first FHC specialist visit?
Bring the complete genetic test report, not only its summary, plus blood results in date order, growth charts, and written reports from any ultrasound, HIDA scan, or liver biopsy. Important labs include total and direct bilirubin, ALT, AST, GGT, and serum bile acids. These records help the care team understand the full picture and avoid unnecessary repeat testing.
What is the chance of having another child with familial hypercholanemia?
If both biological parents are confirmed carriers of pathogenic variants in the relevant gene, each pregnancy has a 25% chance of being affected, a 50% chance of producing a carrier, and a 25% chance of being unaffected. Parental testing and genetic counseling are needed if carrier status or the meaning of a variant is unclear.
Does every child with FHC need a dietitian?
Not necessarily. A pediatric registered dietitian is especially useful when a child has poor growth, malabsorption, or concerns about absorbing vitamins A, D, E, and K. The dietitian can help adjust calories or diet and coordinate nutritional monitoring.
What stool changes should I report to the hepatologist?
Tell the care team about stools that are oily, float, or are very pale, especially if these changes continue or occur with poor growth. These findings may help the team assess digestion or fat absorption, but they do not establish a diagnosis on their own.
Should my family join a familial hypercholanemia registry?
A rare-disease registry may help specialists and researchers understand FHC, but participation is voluntary and does not change your child’s treatment. Ask what information is collected, who can access it, and how consent and privacy are handled. Your child should not undergo an invasive test solely to qualify.
Why does the specialist need the complete genetic report?
The full report shows the exact gene changes and how the laboratory classified them, such as pathogenic or uncertain. A genetic counselor and medical geneticist can compare those findings with your child’s symptoms and explain what they may mean for family members.

Get notified when new evidence is published on Familial hypercholanemia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (15)
  1. 1

    EASL Clinical Practice Guidelines on genetic cholestatic liver diseases.

    Journal of hepatology 2024; (81(2)):303-325 doi:10.1016/j.jhep.2024.04.006.

    PMID: 38851996
  2. 2

    Opinion paper on the diagnosis and treatment of progressive familial intrahepatic cholestasis.

    McKiernan P, Bernabeu JQ, Girard M, et al.

    JHEP reports : innovation in hepatology 2024; (6(1)):100949 doi:10.1016/j.jhepr.2023.100949.

    PMID: 38192535
  3. 3

    Assessment and Management of Cholestasis: Consensus Document of the Spanish Society of Pediatric Gastroenterology, Hepatology and Nutrition (SEGHNP), the Spanish Association of Primary Care Pediatrics (AEPap) and the Spanish Society of Primary Care Pediatrics (SEPEAP).

    Mercadal-Hally M, Loverdos I, Reyes-Andrade J, et al.

    Anales de pediatria 2025; (103(6)):504034 doi:10.1016/j.anpede.2025.504034.

    PMID: 41350188
  4. 4

    SLC10A1 variants causing NTCP deficiency in infants: clinical and functional characterization of a novel splice-site variant.

    Cheng W, Chen F, Pan W, et al.

    BMC pediatrics 2026; (26(1)).

    PMID: 42934621
  5. 5

    Childhood Cholestatic Liver Diseases that Persist Into Adulthood: Lessons for the Adult Gastroenterologist.

    Chan AP, Venick RS

    Journal of clinical gastroenterology 2023; (57(7)):686-693 doi:10.1097/MCG.0000000000001850.

    PMID: 37022007
  6. 6

    Malnutrition in Pediatric Chronic Cholestatic Disease: An Up-to-Date Overview.

    Tessitore M, Sorrentino E, Schiano Di Cola G, et al.

    Nutrients 2021; (13(8)) doi:10.3390/nu13082785.

    PMID: 34444944
  7. 7

    Sodium taurocholate co-transporting polypeptide deficiency.

    Schneider AL, Köhler H, Röthlisberger B, et al.

    Clinics and research in hepatology and gastroenterology 2022; (46(3)):101824 doi:10.1016/j.clinre.2021.101824.

    PMID: 34757153
  8. 8

    Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood.

    Warner S, Rajanayagam J, Russell E, et al.

    JHEP reports : innovation in hepatology 2024; (6(2)):100901 doi:10.1016/j.jhepr.2023.100901.

    PMID: 38235169
  9. 9

    Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients.

    Dong C, Zhang BP, Wang H, et al.

    Medicine 2019; (98(39)):e17305 doi:10.1097/MD.0000000000017305.

    PMID: 31574858
  10. 10

    Genotype-Phenotype Correlations of Monoallelic PFIC Variants in Pediatric Liver Disease: A Multicenter Retrospective Cohort Study.

    Hoskins BJ, Pramparo T, Jarasvaraparn C, et al.

    American journal of medical genetics. Part A 2026; doi:10.1002/ajmg.a.70250.

    PMID: 42477309
  11. 11

    Advancing the Diagnosis and Management of Genetic Cholestatic Liver Disease in Adults.

    Nasir AB, Alkhouri N, Gish R, et al.

    Digestive diseases and sciences 2026; (71(3)):838-851 doi:10.1007/s10620-025-09431-y.

    PMID: 41066043
  12. 12

    Clinical and genetic characteristics of children with sodium taurocholate cotransporting poly-peptide deficiency.

    Du L, Zhou M, Yang J, et al.

    Frontiers in pediatrics 2026; (14()):1784165 doi:10.3389/fped.2026.1784165.

    PMID: 42358581
  13. 13

    [Sodium taurocholate cotransporting polypeptide deficiency manifesting as cholestatic jaundice in early infancy: a complicated case study].

    Song YZ, Deng M

    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics 2017; (19(3)):350-354.

    PMID: 28302211
  14. 14

    Defining the natural history of rare genetic liver diseases: Lessons learned from the NAPPED initiative.

    van Wessel DBE, Gonzales E, Hansen BE, Verkade HJ

    European journal of medical genetics 2021; (64(7)):104245 doi:10.1016/j.ejmg.2021.104245.

    PMID: 33991701
  15. 15

    Baseline Analysis of a Young α-1-Antitrypsin Deficiency Liver Disease Cohort Reveals Frequent Portal Hypertension.

    Teckman JH, Rosenthal P, Abel R, et al.

    Journal of pediatric gastroenterology and nutrition 2015; (61(1)):94-101 doi:10.1097/MPG.0000000000000753.

    PMID: 25651489

This page explains how to organize care for a child with familial hypercholanemia for informational purposes only and does not replace medical advice. Your child’s pediatric hepatologist, geneticist, and other clinicians can tailor care to their needs.

Guide contents Familial hypercholanemia
Research & Literature
04 Long-Term Monitoring and Growth